Novartis AG EPS - Earnings per Share 2010-2025 | NVS

Novartis AG earnings per share (EPS) for the twelve months ending March 31, 2025 was $6.38, a 12.96% decline year-over-year.

  • Novartis AG EPS for the quarter ending March 31, 2025 was $1.82, a 38.93% increase year-over-year.
  • Novartis AG 2024 annual EPS was $5.87, a 17.32% decline from 2023.
  • Novartis AG 2023 annual EPS was $7.1, a 123.97% increase from 2022.
  • Novartis AG 2022 annual EPS was $3.17, a 70.18% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Novartis AG EPS - Earnings per Share 2010-2025 | NVS

  • Novartis AG EPS for the quarter ending March 31, 2025 was $1.82, a 38.93% increase year-over-year.
  • Novartis AG 2024 annual EPS was $5.87, a 17.32% decline from 2023.
  • Novartis AG 2023 annual EPS was $7.1, a 123.97% increase from 2022.
  • Novartis AG 2022 annual EPS was $3.17, a 70.18% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B